Ching Ouyang

1.8k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Ching Ouyang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ching Ouyang has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Ching Ouyang's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ching Ouyang is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Ching Ouyang collaborates with scholars based in United States, Taiwan and Australia. Ching Ouyang's co-authors include Marwan Fakih, Jaideep Sandhu, Joseph Chao, Dean Lim, Idoroenyi Amanam, Samuel J. Klempner, Ethan S. Sokol, Siraj M. Ali, Fadi Braiteh and Alexa B. Schrock and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ching Ouyang

29 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

2019 441 citations Alexa B. Schrock, Ching Ouyang et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching Ouyang United States	15	578	385	355	266	206	31	1.1k
Jean‐Christophe Sabourin France	15	734 1.3×	492 1.3×	243 0.7×	124 0.5×	230 1.1×	29	1.4k
Mikio Kawamura Japan	21	501 0.9×	400 1.0×	333 0.9×	113 0.4×	136 0.7×	64	1.2k
Tomoyuki Momma Japan	23	539 0.9×	479 1.2×	231 0.7×	179 0.7×	341 1.7×	91	1.2k
Zhenhai Lu China	18	554 1.0×	398 1.0×	273 0.8×	91 0.3×	125 0.6×	55	1.1k
Aytekin Akyol Türkiye	14	313 0.5×	464 1.2×	151 0.4×	181 0.7×	91 0.4×	40	964
David A. Leinster United Kingdom	6	486 0.8×	383 1.0×	246 0.7×	71 0.3×	485 2.4×	7	1.1k
Shinobu Umemura Japan	19	428 0.7×	368 1.0×	251 0.7×	130 0.5×	56 0.3×	75	989
Jiaqiang Ma China	13	447 0.8×	431 1.1×	294 0.8×	63 0.2×	494 2.4×	18	1.2k
Suha Deen United Kingdom	19	307 0.5×	349 0.9×	152 0.4×	125 0.5×	244 1.2×	40	960
Vildan Yasasever Türkiye	19	458 0.8×	435 1.1×	195 0.5×	49 0.2×	204 1.0×	53	957

Countries citing papers authored by Ching Ouyang

Since Specialization

Citations

This map shows the geographic impact of Ching Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Ouyang more than expected).

Fields of papers citing papers by Ching Ouyang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Ouyang. The network helps show where Ching Ouyang may publish in the future.

Co-authorship network of co-authors of Ching Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching Ouyang. A scholar is included among the top collaborators of Ching Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching Ouyang. Ching Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Chen, Yaoyao Zhong, Senlin Xu, et al.. (2025). TRIM24 promotes T-cell lymphoma development and glucocorticoid resistance via FUS-mediated phase separation of the glucocorticoid receptor. Drug Resistance Updates. 82. 101270–101270.

Murad, John P., Yukiko Yamaguchi, Ching Ouyang, et al.. (2024). Abstract 6676: Microbiome modification impacts PSCA directed chimeric antigen receptor (CAR) T cell therapy for prostate cancer. Cancer Research. 84(6_Supplement). 6676–6676.

Zhong, Xiancai, Hongmin Wu, Ching Ouyang, et al.. (2023). Ncoa2 Promotes CD8+ T cell–Mediated Antitumor Immunity by Stimulating T-cell Activation via Upregulation of PGC-1α Critical for Mitochondrial Function. Cancer Immunology Research. 11(10). 1414–1431. 15 indexed citations

Hung, Yu‐Wen, Ching Ouyang, Xiaoli Ping, et al.. (2023). Extracellular arginine availability modulates eIF2α O-GlcNAcylation and heme oxygenase 1 translation for cellular homeostasis. Journal of Biomedical Science. 30(1). 32–32. 5 indexed citations

Ouyang, Ching, Yue Qi, Carlos Mendez‐Dorantes, et al.. (2023). Arginine regulates HSPA5/BiP translation through ribosome pausing in triple-negative breast cancer cells. British Journal of Cancer. 129(3). 444–454. 4 indexed citations

Cao, Shuting, Yu‐Wen Hung, Yi-Chang Wang, et al.. (2022). Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 12(13). 6038–6056. 11 indexed citations

Wang, Wei-Le, Ching Ouyang, Kaniel Cassady, et al.. (2022). microRNA-142 guards against autoimmunity by controlling Treg cell homeostasis and function. PLoS Biology. 20(2). e3001552–e3001552. 13 indexed citations

Wang, Chongkai, Jaideep Sandhu, Ching Ouyang, et al.. (2021). Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases. JAMA Network Open. 4(8). e2118416–e2118416. 84 indexed citations

Ouyang, Ching, Yue Qi, Yiyin Chung, et al.. (2020). A Non-canonical Function of BMAL1 Metabolically Limits Obesity-Promoted Triple-Negative Breast Cancer. iScience. 23(2). 100839–100839. 31 indexed citations

10.

Wang, Chongkai, Ching Ouyang, Jaideep Sandhu, Michaël Kahn, & Marwan Fakih. (2020). Wild-type APC and prognosis in metastatic colorectal cancer.. Journal of Clinical Oncology. 38(4_suppl). 223–223. 2 indexed citations

11.

Fakih, Marwan, Ching Ouyang, Chongkai Wang, et al.. (2019). Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. Journal of Clinical Investigation. 129(10). 4464–4476. 62 indexed citations

12.

Wang, Chongkai, John Park, Ching Ouyang, et al.. (2019). Abstract 528: Radioembolization followed by durvalumab and tremelimumab does not induce immune responses against liver-metastasized MSS colorectal cancer. Cancer Research. 79(13_Supplement). 528–528. 1 indexed citations

13.

Schrock, Alexa B., Ching Ouyang, Jaideep Sandhu, et al.. (2019). Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Annals of Oncology. 30(7). 1096–1103. 441 indexed citations breakdown →

14.

Cheng, Chun-Ting, Ching‐Ying Kuo, Ching Ouyang, et al.. (2016). Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells. Cancer Research. 76(17). 5006–5018. 54 indexed citations

15.

Dellinger, Thanh H., David Smith, Ching Ouyang, et al.. (2016). L1CAM is an independent predictor of poor survival in endometrial cancer — An analysis of The Cancer Genome Atlas (TCGA). Gynecologic Oncology. 141(2). 336–340. 59 indexed citations

16.

Ouyang, Ching, David Smith, & Theodore G. Krontiris. (2008). Evolutionary Signatures of Common Human Cis-Regulatory Haplotypes. PLoS ONE. 3(10). e3362–e3362. 8 indexed citations

17.

Ding, Yan, Garrett P. Larson, Guillermo E. Rivas, et al.. (2008). Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk. PLoS ONE. 3(10). e3533–e3533. 11 indexed citations

18.

Ouyang, Ching & Theodore G. Krontiris. (2006). Identification and functional significance of SNPs underlying conserved haplotype frameworks across ethnic populations. Pharmacogenetics and Genomics. 16(9). 667–682. 5 indexed citations

19.

Trivedi, Alpa, Lisa S. Young, Ching Ouyang, Deborah L. Johnson, & Karen U. Sprague. (1999). A TATA Element Is Required for tRNA Promoter Activity and Confers TATA-binding Protein Responsiveness in DrosophilaSchneider-2 Cells. Journal of Biological Chemistry. 274(16). 11369–11375. 11 indexed citations

20.

Ouyang, Ching & Karen U. Sprague. (1998). Cloning and characterization of the TATA-binding protein of the silkworm Bombyx mori. Gene. 221(2). 207–213. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact